| P2093 | author name string | R. Dummer | |
| | G. Burg | |
| | J. C. Becker | |
| | E. B. Bröcker | |
| | A. Schwinn | |
| P2860 | cites work | Preparation of bispecific antibodies by chemical recombination of monoclonal immunoglobulin G1 fragments | Q69951956 |
| | Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors | Q36351101 |
| | The interleukin 2 receptor. Functional consequences of its bimolecular structure | Q36354051 |
| | Molecular heterogeneity of human IgA antibodies during an immune response. | Q36750610 |
| | Production and characterization of tumor infiltrating lymphocyte clones derived from B16-F10 murine melanoma | Q41145561 |
| | Immunocytochemical Analysis of the Cellular Infiltrate in Primary Regressing and Non-Regressing Malignant Melanoma | Q41146869 |
| | Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity | Q41652934 |
| | Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition | Q41679343 |
| | Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures | Q41732697 |
| | Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease. | Q41945849 |
| | Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells | Q42020524 |
| | Activation of peripheral blood T cells via the p75 interleukin 2 receptor | Q42939851 |
| | Mouse melanoma antigen recognized by Lyt-2- and L3T4- cytotoxic T-lymphocytes | Q43549722 |
| | Enhancement of the lytic activity of cloned human CD8 tumour-infiltrating lymphocytes by bispecific monoclonal antibodies | Q43750011 |
| | Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapy. | Q44963202 |
| | Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. | Q44999145 |
| | Human natural killer clones enhance in vitro antibody production by tumour necrosis factor alpha and gamma interferon | Q45037143 |
| | Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones. | Q54384825 |
| | Signal requirements in the step-wise functional maturation of cytotoxic T lymphocytes | Q59068437 |
| | Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. comparison with anti-proliferative activity by RIL1-β, RTNF-α, RIFN-γ, RIl4 and their combinations | Q67654038 |
| | Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions | Q68082648 |
| | Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report | Q68100559 |
| | Activation and inducer subset phenotype of the lymphocytic infiltrate around epidermally derived tumors | Q68557342 |
| | Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells | Q69386256 |
| | Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin-2 | Q69481826 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 121-125 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Tumour-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expression | |
| P478 | volume | 91 | |